INFU — Stock Film
STOCK FILMSCENE 1/11INFU · $8.94
Stock Expert AI presents
INFU
InfuSystem Holdings, Inc
~4 min film100% real numbers0 jargon
WHAT DOES THIS COMPANY DO?
InfuSystem Holdings, Inc. A quick introduction.

On the stock market since 2007, it operates in the world of health and science. It has 502 employees. Now — the numbers.

on the stock market since 2007
502 employees
$180.4M market value
Revenue last year:
$0
The net profit left over:
$0
Out of every $100 in sales, $5 stays as net profit.
THE SLICE THAT TURNS INTO PROFIT: 5%

This is an established company with proven profits.

WHERE DOES THE MONEY COME FROM?
57%Patient Services
Patient Services 57%Device Solutions 43%
57% of all revenue comes from a single line: Patient Services.

That much dependence is a risk in itself: if this one line weakens, the whole company feels it directly.

THE SALES TREND
Sales are growing, year after year.

Average growth of 9% a year over the last 4 years. Every year shown ended in profit.

$102.4M
2021
$109.9M
2022
$125.8M
2023
$134.9M
2024
$143.4M
2025
INSIDE THE REPORT CARD

We compared this company with its own sector across five subjects.

A score of 50 means class average.

BUSINESS QUALITY
91
very strong

Profit power and business quality lead the class.

FINANCIAL STRENGTH
64
average

A solid grade overall — yet the debt outweighs the cash. The strength here comes from earnings power.

VALUATION
86
very strong

The price looks reasonable next to what the company earns.

GROWTH
88
very strong

Sales are growing strongly for its sector.

PRICE MOMENTUM
62
average

The price is looking for direction — no strong breakout, no collapse.

No real weak spot in any of the five subjects — a balanced report card.

THE COUNCIL REVIEW
9

angles, checked one by one.

The 2 that stand out are on screen; the rest came back neutral.

The council scores out of 10; report-card grades are out of 100.

WEAK SPOTS
The stock has lost its spark0/10
Costs eat into the margin4/10
WORTH WATCHING

Cost Efficiency: As sales grow, profit fails to keep the same pace.

THE FIVE-YEAR JOURNEY
Below the peak, but no collapse.

The stock trades 56% below its peak. The market has trimmed its expectations for the company.

1
THE BRIGHT SIDE · 1/3
Sales keep climbing

Over the last 3 years, sales grew about 9% a year on average.

2
THE BRIGHT SIDE · 2/3
Executives are buying their own stock

Over the last 12 months, company executives reported 32 buys and 23 sells. Management buying with its own money is usually read as a good sign.

3
THE BRIGHT SIDE · 3/3
Analysts’ target sits above today’s price

The average analyst price target is $15.0068% above today’s price.

1
THE RISKS · 1/2
The stock has lost its spark

Since the drop from its peak, buyer appetite hasn’t come back. Council score: 0/10.

2
THE RISKS · 2/2
Costs eat into the margin

Costs swallow the gains that sales growth brings in. Council score: 4/10.

FINALE · THE GRADE
A
0 / 100 · MoonshotScore

On our five-subject report card, INFU sits near the top of the class. A high grade doesn’t mean “guaranteed win” — it means “the evidence looks strong for now.”

The takeaway: INFU is an established business that has proven its profits for years. The real debate here isn’t the price — it’s whether the company can keep up this pace.

The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Jul 21, 2026 · stockexpertai.com · Stock Film